SCHEMBL15088270

SCHEMBL15088270

COc1cc(C)ccc1C(=O)N1CCC[C@H](C(=O)Nc2cccc(C(C)(C)C)c2)[C@@H]1c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPK1 P28482 2/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ PRMT5 O14744 2/20 0.39
▸ WDR77 Q9BQA1 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ TACR1 P25103 1/20 0.39
▸ HTR1A P08908 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15088274 0.91 NPSR1 (0.44) MAPK1HCRTR1HCRTR2ROCK2GAA
SCHEMBL13059992 0.91 ALDH1A1 (0.46) ALDH1A1MAPK1GAARXFP1PRMT5
SCHEMBL18609269 0.91 ALDH1A1 (0.46) ALDH1A1MAPK1GAARXFP1PRMT5
SCHEMBL14959054 0.91 ALDH1A1 (0.46) ALDH1A1MAPK1GAARXFP1PRMT5
SCHEMBL18789915 0.91 ALDH1A1 (0.46) ALDH1A1MAPK1GAARXFP1PRMT5
SCHEMBL12176054 0.89 RXFP1 (0.41) ALDH1A1MAPK1HCRTR1HCRTR2RXFP1
SCHEMBL12176578 0.89 ALDH1A1 (0.44) ALDH1A1MAPK1GAARXFP1PRMT5
SCHEMBL24016857 0.86 HSD17B10 (0.46) ALDH1A1GAARXFP1PRMT5WDR77
SCHEMBL14959019 0.86 HSD17B10 (0.46) ALDH1A1GAARXFP1PRMT5WDR77
SCHEMBL18609695 0.86 HSD17B10 (0.46) ALDH1A1GAARXFP1PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102258-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2023-03-30 — — US disclosed
US-20170114017-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2017-04-27 — — US disclosed
US-9573897-B2 C5AR antagonists CHEMOCENTRYX, INC. (US) 2017-02-21 — — US disclosed
US-20160229802-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2016-08-11 — — US disclosed
US-9126939-B2 C5AR antagonists CHEMOCENTRYX, INC. 2015-09-08 — — US disclosed
US-20130172347-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2013-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114017-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 ALDH1A1 2966/4885MAPK1 3645/4885HCRTR1 154/4885
US-20160229802-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 ALDH1A1 2966/4885MAPK1 3645/4885HCRTR1 154/4885
US-20230102258-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 ALDH1A1 2966/4885MAPK1 3645/4885HCRTR1 154/4885
US-20130172347-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 ALDH1A1 2966/4885MAPK1 3645/4885HCRTR1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback